Start-Up Paradigm Raises $200 Million to Speed Up Drug Trials

New York-based Paradigm has raised a significant amount to simplify clinical trials. Its goal is ambitious, but its challenges are many, researchers say.  » mehr lesen

Similar Articles

Most Popular